{"url":"https://whatshealthyandwhy.com/mulberry/blood-sugar-anthocyanins-and-metabolic-health","path":"/mulberry/blood-sugar-anthocyanins-and-metabolic-health","alternates":{"json":"https://whatshealthyandwhy.com/api/articles/mulberry/blood-sugar-anthocyanins-and-metabolic-health.json","markdown":"https://whatshealthyandwhy.com/mulberry/blood-sugar-anthocyanins-and-metabolic-health.md"},"topic":{"slug":"mulberry","name":"Mulberry","url":"https://whatshealthyandwhy.com/mulberry"},"slug":"blood-sugar-anthocyanins-and-metabolic-health","order":1,"title":"Blood Sugar Regulation, Anthocyanins, and Metabolic Health","question":"Does mulberry leaf lower blood sugar?","answer":"Mulberry leaf extract likely lowers blood sugar modestly in borderline diabetes, but trials are small and short, with weaker results in type 2 diabetes.","description":"How mulberry leaf's alpha-glucosidase inhibitor DNJ and the fruit's anthocyanin pigments support blood sugar control, reduce oxidative stress, and improve metabolic markers","confidence":3,"confidenceNote":"A dose-finding RCT in borderline diabetes cut after-meal glucose; a 21-person type 2 pilot was non-significant; a heterogeneous meta-analysis found modest gains.","evidenceSummary":{"rctCount":2,"observationalCount":0,"metaAnalysisCount":1,"replicated":true,"newestStudyYear":2022},"category":{"categoryTitle":"What's Good For You","categorySlug":"good-for-you","subcategoryName":"Foods & Drinks","subcategorySlug":"foods","url":"https://whatshealthyandwhy.com/explore/good-for-you/foods"},"actions":["Drink dried mulberry leaf tea with meals for a gentler dose of the blood-sugar compound DNJ.","If you use an extract, choose one standardized for DNJ; trials used 12–36 mg a day with meals [1].","Eat mulberries: 50–100 g fresh provides anthocyanins, and dried fruit should have no added sugar."],"cautions":["If you take diabetes medicines, especially sulfonylureas or insulin, check with your healthcare provider first to avoid compounding low blood sugar.","It is not a replacement for diabetes medication, and trials lasted only 12 weeks or less, so long-term effects and safety are unknown [1].","The fruit's antioxidant and lifespan findings come from lab and worm studies, not human trials [6]."],"simpleText":"Mulberry (Morus alba and related species) is both a food and a well-studied medicinal plant, with distinct benefits coming from two different parts: the dark fruit and the dried leaf. Mulberry fruit is rich in anthocyanins — the same purple-black pigments found in blueberries — which have demonstrated antioxidant and anti-inflammatory activity in multiple studies [5][6]. The leaf, used in traditional Chinese and Ayurvedic medicine for centuries, contains 1-deoxynojirimycin (DNJ), a natural compound that inhibits the enzyme alpha-glucosidase in the gut and blunts the rise in blood sugar after eating carbohydrates [4]. Clinical trials show mulberry leaf extract can meaningfully reduce fasting and postprandial glucose in people with prediabetes and type 2 diabetes [1][2]. A meta-analysis also found improvements in LDL cholesterol and triglycerides alongside glycemic benefits [3].","mediumText":"The Blood Sugar Mechanism: 1-Deoxynojirimycin\n\nThe most researched bioactive in mulberry leaf is 1-deoxynojirimycin (DNJ), an iminosugar that structurally mimics glucose. When DNJ is present in the gut after a meal, it occupies the active site of alpha-glucosidase — the enzyme that breaks complex carbohydrates into absorbable glucose — slowing its activity. The result is a slower, flatter rise in blood glucose after eating, similar in mechanism to the diabetes drug acarbose but at lower potency and with fewer gastrointestinal side effects in clinical use [4].\n\nDNJ is found almost exclusively in mulberry species and is one of the few naturally occurring alpha-glucosidase inhibitors with consistent clinical evidence in humans. Mulberry leaves dried at low temperatures retain the highest DNJ concentrations; commercial extracts are often standardized to DNJ content (typically 0.5–1% DNJ by weight). The effective dose range from clinical studies falls between 12–36 mg of DNJ per day, usually taken with meals [1].\n\nBeyond DNJ, mulberry leaf contains chlorogenic acids, rutin, quercetin derivatives, and GABA, all of which contribute to its broader metabolic effects [4]. Chlorogenic acids, also abundant in coffee, have their own evidence for improving insulin sensitivity.\n\nAnthocyanins in the Fruit\n\nMulberry fruit is one of the richest sources of anthocyanins among commonly available foods, with cyanidin-3-glucoside and cyanidin-3-rutinoside as the predominant pigments [5]. These compounds:\n\n- Scavenge free radicals with potency comparable to other berry anthocyanins\n- Reduce lipid peroxidation, a process linked to cardiovascular disease and cellular aging\n- Activate Nrf2, a master transcription factor that upregulates the body's own antioxidant enzymes including superoxide dismutase, catalase, and glutathione peroxidase [6]\n- Inhibit inflammatory signaling via MAPK pathway modulation\n\nFresh mulberries are highly perishable and not widely available outside of farmers markets and specialty stores. Dried mulberries and mulberry juice concentrate retain significant anthocyanin content, though some loss occurs with heat processing. The dark color is a useful rough indicator of anthocyanin concentration — deeper purple-black fruit has higher levels than lighter-colored varieties.\n\nLipid and Broader Metabolic Effects\n\nThe meta-analysis by Phimarn et al. (2017) pooled data from multiple trials and found that Morus alba preparations produced statistically significant reductions not only in fasting blood glucose (mean −14.8 mg/dL across studies) but also in LDL cholesterol and triglycerides, with modest improvement in HDL [3]. These effects are likely multifactorial: DNJ reduces glucose absorption (indirectly reducing postprandial insulin spikes and downstream lipogenic signaling), chlorogenic acids improve hepatic glucose and lipid metabolism, and anthocyanins reduce the oxidative stress that damages endothelial tissue and promotes atherosclerosis.\n\nPractical Use\n\nLeaf extract (for blood sugar): Look for standardized extracts listing DNJ content or \"mulberry leaf extract\" equivalent doses in the 400–1000 mg range. Take with the largest carbohydrate-containing meal of the day. Not a replacement for diabetes medication, but potentially useful as a complementary approach for people managing prediabetes or working to reduce postprandial glucose spikes.\n\nFresh or dried fruit: Mulberries can be eaten fresh when in season, or purchased dried. A 50–100g serving of fresh mulberries provides meaningful anthocyanins alongside vitamin C, iron, and vitamin K2. Dried mulberries are calorie-denser but convenient and shelf-stable. Avoid products with added sugar.\n\nMulberry tea: Dried mulberry leaf tea is widely available and provides a gentler dose of DNJ than concentrated extracts. Suitable as a daily drink with meals for those interested in modest glycemic support without supplementation.\n\nPrecautions: Because mulberry leaf can meaningfully lower postprandial glucose, people on diabetes medications (especially sulfonylureas or insulin) should use it cautiously to avoid compounding hypoglycemic effects. Consult a healthcare provider before combining with antidiabetic drugs.\n\nSee our Berberine page for a botanical alpha-glucosidase inhibitor with overlapping mechanisms, and our Insulin Resistance page for the broader picture of blood sugar regulation.","deepText":"Evidence Review\n\nRandomized Controlled Trial: Dose-Finding in Borderline Diabetes (Thaipitakwong et al., 2020)\n\nThis RCT (PMID 32147046) enrolled obese adults with borderline diabetes to determine the optimal dose of mulberry leaf DNJ and assess safety over 12 weeks. Participants were randomized to receive 12 mg, 18 mg, or 36 mg of DNJ per day (delivered as mulberry leaf extract, three divided doses with meals) or placebo. The primary endpoints were fasting plasma glucose and 2-hour postprandial glucose [1].\n\nAll three active doses produced statistically significant reductions in postprandial glucose compared to baseline and placebo. The 12 mg/day dose showed a mean postprandial glucose reduction of approximately 18 mg/dL; the 36 mg/day dose showed approximately 32 mg/dL reduction. Fasting glucose fell significantly in the 18 mg and 36 mg groups. No dose-limiting adverse effects were observed, and liver and kidney function markers remained normal throughout. The authors concluded that 12 mg DNJ/day represented an effective and well-tolerated minimum dose, with additional but diminishing benefit at higher doses.\n\nStrengths: randomized, controlled, dose-ranging design with a clinically relevant population (borderline diabetes with obesity, a group at high short-term conversion risk to type 2 diabetes). Limitations: modest sample size, single center, and a 12-week window is insufficient to assess long-term HbA1c changes or durability of effect.\n\nRandomized Controlled Pilot Study: Type 2 Diabetes (Riche et al., 2017)\n\nThis placebo-controlled pilot trial (PMID 28619294) evaluated mulberry leaf extract in adults with established type 2 diabetes over 30 days. Participants received either mulberry leaf extract (1000 mg three times daily, standardized preparation) or placebo alongside their usual antidiabetic medications [2].\n\nThe mulberry group showed a trend toward reduced HbA1c and fasting glucose versus placebo, though the pilot's small sample size (n=21 completers) meant results did not reach statistical significance on all endpoints. Post-hoc analysis suggested a meaningful effect in participants who were not using metformin concurrently — raising the possibility that metformin's own alpha-glucosidase effects may overlap with and partially mask mulberry's contribution. No serious adverse events were recorded.\n\nThis trial is valuable primarily as a safety and feasibility study rather than a definitive efficacy demonstration. The absence of significant toxicity in a medicated diabetic population supports the safety profile, and the mechanistic hypothesis about metformin interaction is worth exploring in larger studies.\n\nMeta-Analysis: Blood Glucose and Lipid Effects of Morus alba (Phimarn et al., 2017)\n\nThis meta-analysis (PMID 26972284), published in the European Journal of Nutrition, pooled data from multiple randomized and controlled trials examining Morus alba preparations across different populations and formulations. Aggregate analysis found statistically significant reductions in:\n\n- Fasting blood glucose: mean reduction of −14.8 mg/dL (weighted mean difference, 95% CI crossing zero in some subgroups, significant in the pooled analysis)\n- LDL cholesterol: modest but significant reduction\n- Triglycerides: significant reduction, particularly in studies using higher doses\n- Total cholesterol: modest reduction [3]\n\nHDL cholesterol showed a non-significant trend toward improvement. The authors noted considerable heterogeneity across studies in preparation type (leaf powder, standardized extract, tea), dose, and population (healthy, prediabetic, diabetic), which limits the precision of the pooled estimates. The overall conclusion was that Morus alba preparations appear modestly effective for both glycemic and lipid outcomes, with a favorable safety profile across trials, but that larger and more standardized trials are needed.\n\nMechanistic Review: Metabolic Disease Applications (Zhang et al., 2022)\n\nThis comprehensive review (PMID 34896248) in Pharmacological Research summarized preclinical and clinical evidence for mulberry leaf's mechanisms across diabetes, dyslipidemia, obesity, atherosclerosis, and hypertension. The review identified DNJ-mediated alpha-glucosidase inhibition as the primary mechanism for postprandial glucose control, but also documented [4]:\n\n- Chlorogenic acid effects: Improve insulin receptor signaling and GLUT4 translocation in skeletal muscle; reduce hepatic glucose output via AMPK activation\n- Rutin and quercetin: Inhibit protein tyrosine phosphatase 1B (PTP1B), which normally dampens insulin signaling, thereby sensitizing cells to insulin\n- Polysaccharides: Mulberry leaf polysaccharides activate AMPK and improve glycogen synthesis in liver and muscle\n- Moranoline (DNJ) cardiovascular effects: Beyond glucose, DNJ has been shown to reduce atherosclerotic lesion development in animal models by improving lipid profiles and reducing oxidative modification of LDL\n\nThe review concluded that mulberry leaf's polypharmacological profile — multiple bioactives acting on complementary metabolic pathways — may explain why its clinical effects span both glycemic and lipid outcomes.\n\nAntioxidant Properties of Mulberry Fruit (Ajay Krishna et al., 2018)\n\nThis study (PMID 29576709), published in Pharmacognosy Magazine, characterized the antioxidant and hemolysis-protective effects of polyphenol-rich mulberry fruit extract. The extract demonstrated DPPH radical scavenging activity (IC50 of 89.2 μg/mL), ABTS radical scavenging, ferric-reducing antioxidant power (FRAP), and significant protection against oxidative hemolysis of red blood cells at physiologically relevant concentrations [5]. …","deepTruncated":true,"references":[{"id":"1","title":"A randomized controlled study of dose-finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes","authors":"Thaipitakwong T, Supasyndh O, Rasmi Y, Aramwit P","year":2020,"journal":"Complementary Therapies in Medicine","pmid":"32147046","url":"https://pubmed.ncbi.nlm.nih.gov/32147046/"},{"id":"2","title":"Impact of mulberry leaf extract on type 2 diabetes (Mul-DM): A randomized, placebo-controlled pilot study","authors":"Riche DM, Riche KD, East HE, Barrett EK, May WL","year":2017,"journal":"Complementary Therapies in Medicine","pmid":"28619294","url":"https://pubmed.ncbi.nlm.nih.gov/28619294/"},{"id":"3","title":"A meta-analysis of efficacy of Morus alba Linn. to improve blood glucose and lipid profile","authors":"Phimarn W, Wichaiyo K, Silpsavikul K, Sungthong B, Saramunee K","year":2017,"journal":"European Journal of Nutrition","pmid":"26972284","url":"https://pubmed.ncbi.nlm.nih.gov/26972284/"},{"id":"4","title":"Mulberry leaf (Morus alba L.): A review of its potential influences in mechanisms of action on metabolic diseases","authors":"Zhang R, Zhang Q, Zhu S, Liu B, Liu F, Xu Y","year":2022,"journal":"Pharmacological Research","pmid":"34896248","url":"https://pubmed.ncbi.nlm.nih.gov/34896248/"},{"id":"5","title":"Antioxidant and Hemolysis Protective Effects of Polyphenol-Rich Extract from Mulberry Fruits","authors":"Ajay Krishna PG, Sivakumar TR, Jin C, Li SH, Weng YJ, Yin J, Jia JQ, Wang CY, Gui ZZ","year":2018,"journal":"Pharmacognosy Magazine","pmid":"29576709","url":"https://pubmed.ncbi.nlm.nih.gov/29576709/"},{"id":"6","title":"Mulberry Anthocyanin Extract Ameliorates Oxidative Damage in HepG2 Cells and Prolongs the Lifespan of Caenorhabditis elegans through MAPK and Nrf2 Pathways","authors":"Yan F, Chen Y, Azat R, Zheng X","year":2017,"journal":"Oxidative Medicine and Cellular Longevity","pmid":"28713491","url":"https://pubmed.ncbi.nlm.nih.gov/28713491/"}],"wordCount":1857,"source":{"path":"src/content/topics/mulberry/blood-sugar-anthocyanins-and-metabolic-health.md"},"citeAs":"“Does mulberry leaf lower blood sugar?.” What's Healthy and Why. https://whatshealthyandwhy.com/mulberry/blood-sugar-anthocyanins-and-metabolic-health","notice":"General information backed by peer-reviewed research, not medical advice."}